| Name: |
Sonic Healthcare Limited |
| Registered Office: |
Level 22
225 George Street
Sydney NSW 2000
Australia |
| Board of Directors: |
| Professor Mark Compton |
Non-executive, Independent Director |
| Dr Colin Goldschmidt |
Executive Director |
| Christopher Wilks |
Executive Director |
| Emeritus Professor Christine Bennett |
Non-executive, Independent Director |
| Professor Suzanne Crowe |
Non-executive, Independent Director |
| Dr Katharine Giles |
Non-executive, Independent Director |
| Neville Mitchell |
Non-executive, Independent Director |
| Lou Panaccio |
Non-executive, Independent Director |
| Kate Spargo |
Non-executive, Independent Director |
|
| Company Secretary: |
Paul Alexander |
| Auditor: |
PricewaterhouseCoopers |
| Bankers: |
Australia and New Zealand Banking Group
BNP Paribas
Commerzbank
Commonwealth Bank of Australia
Crédit Industriel et Commercial
DNB Asia
HSBC
JPMorgan Chase Bank
Mizuho Bank
MUFG Bank
National Australia Bank
Westpac Banking Corporation
|
| Listings: |
Sonic Healthcare Limited shares are traded on the Australian Securities Exchange. The code is "SHL.AX".
|
| American Depositary Receipt Program |
Sonic Healthcare Limited has a Level I sponsored American Depositary Receipt (ADR) facility managed by BNY Mellon. Sonic Healthcare Limited’s ADRs are traded under the code “SKHHY”. The ADR’s are not listed on any exchange and are only traded over-the-counter via brokers.
|
